£179.95

Wiley Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Price data last checked 27 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£180 today · all-time low £178 (Jun 2026) · usually £180

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£207.66 £174.91 £182.06 £189.20 £196.35 £203.49 £210.64 25 April 2026 10 May 2026 26 May 2026 11 June 2026 27 June 2026

Price Distribution

Price distribution over 64 days • 4 price levels

Days at Price
Current Price
8 days 4 days · current 31 days 21 days 0 8 16 23 31 £178 £180 £205 £208 Days at Price

Price Analysis

Most common price: £205 (31 days, 48.4%)

Price range: £178 - £208

Price levels: 4 different prices over 64 days

Description

Prominent Alzheimer's investigators provide a comprehensive and balanced overview of the neuropharmacological basis for therapeutics in this devastating disease. Divided into three parts, the book begins with basic research on the neurobiology of cognitive function, offering relevant information on the way the brain encodes and stores data. The second segment explores the molecular aspects of Alzheimer's Disease (AD), emphasizing investigations of possible etiological factors. In the final section, a variety of issues important in developing treatments are discussed including cholinergic-based treatments, the role of neuroinflammin in AD and the therapeutic potential of anti-inflammatory agents. From the Inside Flap In recent years, research on Alzheimer's disease has become one of the most intensely pursued areas in the field of neuroscience. Despite the wealth of information gathered, however, relatively little of what has been learned has resulted in the development of effective treatments. Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations gathers the top investigators in the area of Alzheimer's research and presents their pioneering work on potential treatments for this devastating disease. Combining current knowledge of the neurobiology of memory with molecular studies related to disease etiology, this book provides a comprehensive review of the latest research on Alzheimer's as well as a thorough examination of current experiments with drugs that could correct the biochemical defects that cause Alzheimer's or ameliorate the associated cognitive deficits. Each of the book's three sections, "Neurobiology of Cognition," "Molecular Aspects of Alzheimer's Disease," and "Alzheimer's Drug Discovery and Development," is a collection of the most recent studies by prominent specialists in their respective fields. Among the numerous topics covered: * Structure and dynamics of multiple memory systems in Alzheimer's disease * Interaction of neuromodulatory systems regulating memory storage * Neuropsychological features of Alzheimer's disease * Normal brain aging and Alzheimer's disease pathology * Recent developments in the genetics of Alzheimer's disease * Animal models relevant to Alzheimer's disease * Considerations for clinical trials in Alzheimer's disease * A fundamental role for estrogens in cognition and neuroprotection * Alzheimer's disease: prospects for treatment in the next decade. A comprehensive and balanced overview of the most critically important information available, Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations heralds a new phase in the process of studying this uniquely human disease: the search for treatments. It is must reading for neuroscientists, pharmacologists, medicinal chemists, and academic physicians involved in basic research and clinical trials, as well as for clinicians who treat Alzheimer's patients. From the Back Cover In recent years, research on Alzheimer's disease has become one of the most intensely pursued areas in the field of neuroscience. Despite the wealth of information gathered, however, relatively little of what has been learned has resulted in the development of effective treatments. Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations gathers the top investigators in the area of Alzheimer's research and presents their pioneering work on potential treatments for this devastating disease. Combining current knowledge of the neurobiology of memory with molecular studies related to disease etiology, this book provides a comprehensive review of the latest research on Alzheimer's as well as a thorough examination of current experiments with drugs that could correct the biochemical defects that cause Alzheimer's or ameliorate the associated cognitive deficits. Each of the book's three sections, "Neurob

Product Specifications

Brand
Wiley
Format
hardcover
Domain
Amazon UK
Release Date
21 March 1997
Listed Since
15 December 2006

Barcode

No barcode data available

Similar Products You Might Like

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
97% match

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Academic Press

£114.19 21 Jun 2026
Neuroprotection in Alzheimer's Disease
97% match

Neuroprotection in Alzheimer's Disease

Academic Press

£88.59 10 Jul 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
97% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£82.10 05 Jul 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
97% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 03 Jul 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
97% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.81 09 Jul 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
97% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£92.39 02 Jul 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
97% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£11.43 04 Jul 2026
The End of Alzheimer's: The Brain and Beyond
97% match

The End of Alzheimer's: The Brain and Beyond

Academic Press

£50.59 07 Jul 2026
Practical Pharmacology for Alzheimer’s Disease
96% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£145.35 14 Jul 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Jul 2026
Practical Pharmacology for Alzheimer’s Disease
96% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£76.63 14 Jul 2026
Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)
96% match

Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)

Springer

£138.70 30 Jun 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
96% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£69.91 03 Jul 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
96% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£66.04 10 Jul 2026
Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, And Treatment (American Academy Of Clinical Neuropsychology Oxford Workshop) (AACN Workshop Series)
96% match

Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, And Treatment (American Academy Of Clinical Neuropsychology Oxford Workshop) (AACN Workshop Series)

Oxford University Press

£59.61 03 Jul 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 13 Jul 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
96% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£105.49 09 Jul 2026
ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)
96% match

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)

Imperial College Press

£80.01 30 Jun 2026
Clinical Diagnosis and Management of Alzheimer's Disease
96% match

Clinical Diagnosis and Management of Alzheimer's Disease

CRC Press

£87.47 23 Jun 2026
Dementia: 3 (NIP- Neurology in Practice)
96% match

Dementia: 3 (NIP- Neurology in Practice)

Wiley-Blackwell

£54.20 06 Jul 2026